We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharma has good first half.
- Authors
Eisberg, Neil
- Abstract
The article reports on the revenue increase of pharmaceutical companies in the U.S., Europe and Asia during the first half of 2008. It mentions the U.S. companies' growth in sales like Bristol-Myers Squibb by 16%, Pfizer's by 15%, Wyeth by 6%, Eli Lilly by 12% and 14.3% for Abbott. Revenue growth of drug companies in Europe is also mentioned including Merck KGaA's 18.1%, Roche's 10%, 3% for GlaxoSmithKline of Great Britain, and 11% for Switzerland's Novartis. India's Dr. Reddy's with 25% increase is also included.
- Subjects
REVENUE management; PHARMACEUTICAL industry; BRISTOL-Myers Squibb Co.; PFIZER Inc.; WYETH (Company : 1860-2009); ELI Lilly &; Co.; ABBOTT (Company); MERCK KGaA; F. Hoffmann-La Roche Ltd.; GLAXOSMITHKLINE; NOVARTIS AG; DR. Reddy's Laboratories Ltd.
- Publication
Chemistry & Industry, 2008, Issue 15, p5
- ISSN
0009-3068
- Publication type
Article